US 9689042
Use of glycolytic pathways for inhibiting or measuring oncogenic signaling
granted A61KA61K2039/517
Quick answer
US patent 9689042 (Use of glycolytic pathways for inhibiting or measuring oncogenic signaling) held by The Regents of the University of California expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/517